Joana S. Rodrigues
University of Santiago de Compostela
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joana S. Rodrigues.
Neuroendocrinology | 2015
Montserrat Garcia-Lavandeira; Esther Diaz-Rodriguez; Dilek Bahar; Angela R. Garcia-Rendueles; Joana S. Rodrigues; Carlos Dieguez; Clara V. Alvarez
The recent demonstration using genetic tracing that in the adult pituitary stem cells are normally recruited from the niche in the marginal zone and differentiate into secretory cells in the adenopituitary has elegantly confirmed the proposal made when the pituitary stem cell niche was first discovered 5 years ago. Some of the early controversies have also been resolved. However, many questions remain, such as which are the markers that make a pituitary stem cell truly unique and the exact mechanisms that trigger recruitment from the niche. Little is known about the processes of commitment and differentiation once a stem cell has left the niche. Moreover, the acceptance that pituitary cells are renewed by stem cells implies the existence of regulated mechanisms of cell death in differentiated cells which must themselves be explained. The demonstration of an apoptotic pathway mediated by RET/caspase 3/Pit-1/Arf/p53 in normal somatotrophs is therefore an important step towards understanding how pituitary cell number is regulated. Further work will elucidate how the rates of the three processes of cell renewal, differentiation and apoptosis are balanced in tissue homeostasis after birth, but altered in pituitary hyperplasia in response to physiological stimuli such as puberty and lactation. Thus, we can aim to understand the mechanisms underlying human disease due to insufficient (hypopituitarism) or excess (pituitary tumor) cell numbers.
Frontiers of Hormone Research | 2010
Montserrat Garcia-Lavandeira; Esther Diaz-Rodriguez; María E.R. García-Rendueles; Joana S. Rodrigues; Sihara Perez-Romero; Susana B. Bravo; Clara V. Alvarez
The RET receptor is a tyrosine kinase receptor implicated in kidney and neural development. In the adenopituitary RET and the co-receptor GFRa1 are expressed exclusively in the somatotrophs secreting GH. RET is implicated in a clever pathway to maintain at physiological levels the number of somatotrophs and the GH production. Thus, in absence of its ligand GDNF, RET induces apoptosis through massive expression of Pit-1 leading to p53 accumulation. In the presence of the ligand GDNF, RET activates its tyrosine kinase and promotes survival at the expense of reducing Pit-1 expression and downregulating GH. Recent data suggest that RET can also have a second role in pituitary plasticity through a second co-receptor GFRa2.
The Journal of Clinical Endocrinology and Metabolism | 2013
Susana B. Bravo; María E.R. García-Rendueles; Angela R. Garcia-Rendueles; Joana S. Rodrigues; Sihara Perez-Romero; Montserrat Garcia-Lavandeira; Maria Suarez-Fariña; Francisco Barreiro; Barbara Czarnocka; Ana Senra; Maria V. Lareu; Javier Rodríguez-García; José Cameselle-Teijeiro; Clara V. Alvarez
CONTEXT Mechanisms of thyroid physiology and cancer are principally studied in follicular cell lines. However, human thyroid cancer lines were found to be heavily contaminated by other sources, and only one supposedly normal-thyroid cell line, immortalized with SV40 antigen, is available. In primary culture, human follicular cultures lose their phenotype after passage. We hypothesized that the loss of the thyroid phenotype could be related to culture conditions in which human cells are grown in medium optimized for rodent culture, including hormones with marked differences in its affinity for the relevant rodent/human receptor. OBJECTIVE The objective of the study was to define conditions that allow the proliferation of primary human follicular thyrocytes for many passages without losing phenotype. METHODS Concentrations of hormones, transferrin, iodine, oligoelements, antioxidants, metabolites, and ethanol were adjusted within normal homeostatic human serum ranges. Single cultures were identified by short tandem repeats. Human-rodent interspecies contamination was assessed. RESULTS We defined an humanized 7 homeostatic additives medium enabling growth of human thyroid cultures for more than 20 passages maintaining thyrocyte phenotype. Thyrocytes proliferated and were grouped as follicle-like structures; expressed Na+/I- symporter, pendrin, cytokeratins, thyroglobulin, and thyroperoxidase showed iodine-uptake and secreted thyroglobulin and free T3. Using these conditions, we generated a bank of thyroid tumors in culture from normal thyroids, Graves hyperplasias, benign neoplasms (goiter, adenomas), and carcinomas. CONCLUSIONS Using appropriate culture conditions is essential for phenotype maintenance in human thyrocytes. The bank of thyroid tumors in culture generated under humanized humanized 7 homeostatic additives culture conditions will provide a much-needed tool to compare similarly growing cells from normal vs pathological origins and thus to elucidate the molecular basis of thyroid disease.
Analytical Biochemistry | 2010
Susana B. Bravo; María E.R. García-Rendueles; Sihara Perez-Romero; José Cameselle-Teijeiro; Joana S. Rodrigues; Francisco Barreiro; Clara V. Alvarez
Recently, it has been shown that commercial human thyroid lines were in fact derived from colon, mammary carcinoma, or melanoma. Others have demonstrated the absence of a common pattern of gene expression between available thyroid cancer cell lines and tumors from patients. Thus, it is important to use several primary cells with a common pathological origin to achieve reproducible results, and it is necessary to find common methods for manipulation of protein expression in such various cultures. We have standardized a transfection method for efficient expression of exogenous proteins in human primary thyroid cultures. We compared lipid-based techniques with three electroporation systems (Electroporator PulseAgile [PA]-4000, Microporator MP-100, and Nucleofector II). Nucleofection was unquestionably the most efficient even for promoter regulation studies, and it was effective in cultures from different origins as normal thyroid, papillary carcinoma, or lymphoid node metastasis. We also standardized, through lentiviral infection, the short hairpin RNA downregulation of protein expression generating human thyrocytes with low levels of p27KIP1 as a model system.
Journal of Molecular Endocrinology | 2012
Clara V. Alvarez; Montserrat Garcia-Lavandeira; María E.R. García-Rendueles; Esther Diaz-Rodriguez; Angela R. Garcia-Rendueles; Sihara Perez-Romero; Tania Vila Vila; Joana S. Rodrigues; Pamela Virginia Lear; Susana B. Bravo
Endocrine Abstracts | 2018
Miguel Chenlo; Joana S. Rodrigues; Manuel Narciso Blanco Freire; Carmen Suarez Farina Maria del; Magalí Piso-Neira; José Cameselle-Teijeiro; Clara V. Alvarez
ESE Basic Endocrinology Course on Endocrine and Neuroendocrine Cancer 2016 | 2016
Joana S. Rodrigues; Angela R. Garcia-Rendueles; María E.R. García-Rendueles; María Suárez Fariña; Sihara Perez-Romero; Ignacio Bernabeu; Javier Rodríguez-García; Laura Fugazzola; Toshiyuki Sakai; Fang Liu; José Cameselle-Teijeiro; Susana B. Bravo; Clara V. Alvarez
Archive | 2015
Montserrat García Lavandeira; Esther Díaz Rodríguez; Ángela García Rendueles; Dilek Bahar; Joana S. Rodrigues; Elvin Aliyev; María Suárez Fariña; Sihara Pérez Romero; Clara Álvarez Villamarín
Actualización en neuroendocrinología | 2015
Montserrat García Lavandeira; Esther Díaz Rodríguez; Ángela García Rendueles; Dilek Bahar; Joana S. Rodrigues; Elvin Aliyev; María Suárez Fariña; Sihara Pérez Romero; Clara Álvarez Villamarín
15th European Congress of Endocrinology | 2013
Joana S. Rodrigues; Ángela Marcela Ochoa Rodríguez; Sihara Pérez; Francisco Barreiro; José Cameselle-Teijeiro; Maria C. Rodríguez; Susana B. Bravo; Clara V. Alvarez